Kayne Anderson Rudnick Investment Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-456,778
| Closed | -$6.85M | – | 989 |
|
2023
Q3 | $6.85M | Sell |
456,778
-897,930
| -66% | -$13.5M | 0.02% | 273 |
|
2023
Q2 | $44M | Sell |
1,354,708
-16,958
| -1% | -$551K | 0.12% | 136 |
|
2023
Q1 | $53.7M | Buy |
1,371,666
+21,352
| +2% | +$836K | 0.16% | 124 |
|
2022
Q4 | $71.4M | Sell |
1,350,314
-54,474
| -4% | -$2.88M | 0.22% | 114 |
|
2022
Q3 | $63.2M | Buy |
1,404,788
+57,544
| +4% | +$2.59M | 0.21% | 115 |
|
2022
Q2 | $49M | Buy |
1,347,244
+28,339
| +2% | +$1.03M | 0.15% | 131 |
|
2022
Q1 | $54.5M | Buy |
1,318,905
+39,628
| +3% | +$1.64M | 0.14% | 137 |
|
2021
Q4 | $54.5M | Sell |
1,279,277
-26,074
| -2% | -$1.11M | 0.13% | 146 |
|
2021
Q3 | $71.8M | Buy |
1,305,351
+21,305
| +2% | +$1.17M | 0.17% | 132 |
|
2021
Q2 | $61.5M | Buy |
1,284,046
+380,400
| +42% | +$18.2M | 0.15% | 138 |
|
2021
Q1 | $45.8M | Buy |
903,646
+32,464
| +4% | +$1.64M | 0.12% | 148 |
|
2020
Q4 | $54.9M | Buy |
871,182
+76,399
| +10% | +$4.81M | 0.16% | 132 |
|
2020
Q3 | $53.4M | Buy |
794,783
+344,465
| +76% | +$23.2M | 0.19% | 113 |
|
2020
Q2 | $18.9M | Buy |
450,318
+138,338
| +44% | +$5.8M | 0.08% | 160 |
|
2020
Q1 | $9.82M | Buy |
311,980
+87,446
| +39% | +$2.75M | 0.06% | 172 |
|
2019
Q4 | $9.07M | Buy |
224,534
+29,347
| +15% | +$1.19M | 0.04% | 188 |
|
2019
Q3 | $6.35M | Buy |
195,187
+51,986
| +36% | +$1.69M | 0.03% | 204 |
|
2019
Q2 | $6.94M | Buy |
+143,201
| New | +$6.94M | 0.04% | 199 |
|